Difficulty speaking : Myasthenia gravis can cause speech to become slurred or nasal, and can become especially noticeable after prolonged speaking
While cosmetically concerning, they rarely affect medication absorption
Recovery of ergosterol from Agaricus bisporus mushrooms via supercritical fluid extraction: a response surface methodology optimisation
Endocrinol.: The maintenance of long-term weight loss after semaglutide withdrawal in obese women with PCOS treated with metformin Harvard Health Publishing: Diet & Weight Loss Healthline: Is Body Roundness Index the New BMI
The future of metabolic medicine is personalized, preventive, and patient-centered
Tirzepatide is a first-in-class dual incretin receptor agonist a single molecule that activates both the GIP (glucose-dependent insulinotropic polypeptide) and the GLP-1 (glucagon-like peptide-1) receptors, which is why it is often nicknamed a twincretin. [7] By engaging two incretin pathways it enhances glucose-dependent insulin secretion, promotes satiety, and delays gastric emptying, producing large effects on both glycemic control and bodyweight